Infographic: Antibody Therapy for Neurodegenerative Diseases
Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.
Alzheimer's disease
Small but Powerful: Small Molecule Drug Design
LIVE August 26th, 2021 at 11:00 AM ET
In this webinar, experts will discuss new approaches to identify small therapeutic candidates targeting diabetes and Alzheimer’s disease.
Gene-Edited Stem Cells for Disease and Drug Discovery
LIVE June 17th, 2021 at 2:30 PM ET
This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.
This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.
Cholesterol may be key to new Alzheimer’s and diabetes therapies
University of Arizona researcher looks beyond traditional causes to find novel therapies
Antibody against Alzheimer’s
Lilly’s donanemab Phase 2 trial brings positive results
Dapansutrile proves promising for Alzheimer’s
Dapansutrile prevents inflammatory response, and restores cognitive and behavioral deficits in an Alzheimer’s mouse model
Targeting beta amyloid oligomers
Four compounds show promise against Alzheimer’s
Special delivery
Natural compound attacks Alzheimer’s disease early
Keeping an eye on neurodegeneration
Potential biomarker for Alzheimer’s, Parkinson’s and other diseases can be found in the eye
